Caution urged over the FDA's new breakthrough designation

被引：1

|

作者：

Jiang, Kevin

机构：

来源：

NATURE MEDICINE | 2013年 / 19卷 / 10期

关键词：

D O I：

10.1038/nm1013-1196a

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：1196 / 1196

页数：1

相关论文

共 50 条

[1] Caution urged over the FDA's new breakthrough designation
Kevin Jiang
Nature Medicine, 2013, 19 : 1196 - 1196
[2] Expediting Drug Development - The FDA's New "Breakthrough Therapy" Designation
Sherman, Rachel E.
Li, Jun
Shapley, Stephanie
Robb, Melissa
Woodcock, Janet
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (20): : 1877 - 1880
[3] Caution urged over labelling on new PVAs
不详
MATERIALS & DESIGN, 1997, 18 (01): : 44 - 44
[4] Breakthrough therapy: FDA's new designation for accelerating approval of promising pipeline therapies
Calabrese, David
FORMULARY, 2013, 48 (08) : 275 - 276
[5] Reflections on 10 years of the FDA's breakthrough therapy designation
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) : 252 - 253
[6] Two cancer immunotherapeutics received FDA's breakthrough designation
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 809 - 809
[7] Physician Perceptions of the FDA's Breakthrough Therapy Designation: An Update
Paquin, Ryan S.
Boudewyns, Vanessa
O'Donoghue, Amie C.
Aikin, Kathryn J.
ONCOLOGIST, 2022, 27 (01): : E85 - E88
[8] Reflections on 10 years of the FDA’s breakthrough therapy designation
Asher Mullard
Nature Reviews Drug Discovery, 2022, 21 : 252 - 253
[9] Breakthrough-Therapy Designation - An FDA Perspective
Corrigan-Curay, Jacqueline
Mckee, Amy E.
Stein, Peter
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (15): : 1457 - 1458
[10] Rapastinel receives FDA breakthrough therapy designation
不详
NURSE PRACTITIONER, 2016, 41 (04): : 56 - 56

← 1 2 3 4 5 →